Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
2.
Infect Immun ; 64(4): 1351-6, 1996 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-8606100

RESUMO

Depressed Th1 responses are a prominent feature of human tuberculosis, but an enhanced Th2 response has not been detected in peripheral blood T cells stimulated in vitro with Mycobacterium tuberculosis. In disease due to Mycobacterium leprae, Th2 cells predominate in tissue lesions of patients with extensive disease but are absent from peripheral blood. To determine if Th2 cells are present in tissue lesions of tuberculosis patients, we evaluated patterns of cytokine expression in lymph nodes from tuberculosis patients with or without human immunodeficiency virus infection and in controls without tuberculosis. Gamma interferon and interleukin-10 (IL-10) mRNA expression in tuberculosis patients with or without human immunodeficiency virus infection was high, whereas IL-4 expression in the same patients was low. Immunolabeling studies showed that macrophage production of IL-12 was increased in lymph nodes from tuberculosis patients, that gamma interferon was produced by T cells, and that IL-10 was produced by macrophages rather than Th2 cells. These results indicate that Th2 responses are not enhanced either systemically or at the site of disease in human tuberculosis.


Assuntos
Interleucina-10/biossíntese , Interleucina-4/biossíntese , Células Th2/imunologia , Tuberculose/imunologia , Infecções por HIV/imunologia , Humanos , Interleucina-10/genética , Interleucina-4/genética , Linfonodos/imunologia , RNA Mensageiro/análise
3.
Int J Lepr Other Mycobact Dis ; 57(3): 622-7, 1989 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-2778368

RESUMO

Thirty-three active multibacillary patients from nine counties of Weifang Prefecture, Shandong Province, and 47 active cases from Menla County, Yunnan Province, People's Republic of China, were treated with 24 and 27 months of multidrug therapy (MDT), respectively, in 1983. Clinical assessments, smears, and histopathologic examinations were carried out independently by study teams from the Institutes of Dermatology of these two provinces. Reexaminations at 12-14 months and at termination of therapy showed marked improvement, and there was continued improvement at 12-18 and 33 months on follow up. Conversion of the bacterial index to negativity was 0/33, 5/47 for the patients from Shandong and Yunnan provinces, respectively, at the end of MDT and 2/33 at 12 months' and 17/47 at 18 months' follow up, which increased to 21/33 and 26/44 at 33 months' follow up. Regression of specific infiltration was about 21%-100% after 24-27 months of MDT; further regression to 95%-100% occurred at 33 months' follow up.


Assuntos
Hansenostáticos/uso terapêutico , Hanseníase/tratamento farmacológico , Adulto , China , Clofazimina/efeitos adversos , Clofazimina/uso terapêutico , Dapsona/efeitos adversos , Dapsona/uso terapêutico , Quimioterapia Combinada , Feminino , Humanos , Hansenostáticos/efeitos adversos , Hanseníase Dimorfa/tratamento farmacológico , Hanseníase Virchowiana/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Rifampina/efeitos adversos , Rifampina/uso terapêutico , Pele/efeitos dos fármacos , Pele/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA